Projected Income Statement: Givaudan SA

Forecast Balance Sheet: Givaudan SA

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 4,040 4,390 4,530 4,305 4,002 3,692 3,376 2,983
Change - 8.66% 3.19% -4.97% -7.04% -7.75% -8.56% -11.64%
Announcement Date 1/29/21 1/28/22 1/25/23 1/25/24 1/24/25 - - -
1CHF in Million
Estimates

Cash Flow Forecast: Givaudan SA

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
CAPEX 1 227 256 304 275 293 307.8 310.1 324.4
Change - 12.78% 18.75% -9.54% 6.55% 5.04% 0.76% 4.61%
Free Cash Flow (FCF) 1 906 1,032 644 1,098 1,332 992.7 1,169 1,195
Change - 13.91% -37.6% 70.5% 21.31% -25.47% 17.81% 2.15%
Announcement Date 1/29/21 1/28/22 1/25/23 1/25/24 1/24/25 - - -
1CHF in Million
Estimates

Forecast Financial Ratios: Givaudan SA

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027

Profitability

        
EBITDA Margin (%) 22.1% 22.17% 20.74% 21.3% 23.81% 24.37% 24.18% 24.1%
EBIT Margin (%) 15.75% 16.29% 15.62% 16.14% 18.81% 19.31% 19.51% 19.5%
EBT Margin (%) 13.86% 14.44% 13.04% 14.3% 17.71% 17.56% 17.77% 17.86%
Net margin (%) 11.75% 12.28% 12.03% 12.91% 14.71% 14.62% 14.87% 14.98%
FCF margin (%) 14.33% 15.44% 9.05% 15.88% 17.97% 13.24% 15.05% 14.66%
FCF / Net Income (%) 121.94% 125.7% 75.23% 122.96% 122.2% 90.6% 101.23% 97.89%

Profitability

        
ROA 7.06% 7.44% 7.46% 7.89% 9.39% 9.42% 9.57% 9.93%
ROE 20.84% 22.13% 20.98% 21.71% 25.43% 24.21% 23.16% 22.52%

Financial Health

        
Leverage (Debt/EBITDA) 2.89x 2.96x 3.07x 2.92x 2.27x 2.02x 1.8x 1.52x
Debt / Free cash flow 4.46x 4.25x 7.03x 3.92x 3x 3.72x 2.89x 2.5x

Capital Intensity

        
CAPEX / Current Assets (%) 3.59% 3.83% 4.27% 3.98% 3.95% 4.11% 3.99% 3.98%
CAPEX / EBITDA (%) 16.25% 17.27% 20.6% 18.67% 16.6% 16.85% 16.51% 16.52%
CAPEX / FCF (%) 25.06% 24.81% 47.2% 25.05% 22% 31% 26.52% 27.16%

Items per share

        
Cash flow per share 1 121.9 138.6 102.5 148.7 175.4 157.7 164.6 172.8
Change - 13.69% -26.1% 45.14% 17.93% -10.09% 4.41% 4.97%
Dividend per Share 1 64 66 67 68 68 72.26 75.01 77.06
Change - 3.12% 1.52% 1.49% 0% 6.27% 3.81% 2.72%
Book Value Per Share 1 375.6 422.9 458.7 432.4 495.8 535.4 581.3 638.4
Change - 12.59% 8.46% -5.72% 14.65% 7.98% 8.57% 9.83%
EPS 1 79.96 88.37 92.51 96.47 117.6 117.6 124.4 131.5
Change - 10.52% 4.68% 4.28% 21.93% -0.07% 5.79% 5.71%
Nbr of stocks (in thousands) 9,229 9,228 9,227 9,227 9,227 9,229 9,229 9,229
Announcement Date 1/29/21 1/28/22 1/25/23 1/25/24 1/24/25 - - -
1CHF
Estimates
2025 *2026 *
P/E ratio 26.9x 25.4x
PBR 5.91x 5.44x
EV / Sales 4.39x 4.19x
Yield 2.28% 2.37%
More valuation ratios * Estimated data

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
AAA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
3,165.00CHF
Average target price
3,960.90CHF
Spread / Average Target
+25.15%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. GIVN Stock
  4. Financials Givaudan SA